Margaret Sibley, PhD

Personal Statement

My work focuses on the diagnosis and treatment of ADHD in adolescents and adults. As part of this work I conduct clinical trials evaluating school, community, and parent based treatments for teens with in attention, motivation, and executive function challenges. I also am an investigator on several longitudinal studies of ADHD, including the Multimodal Treatment of ADHD (MTA) study. I have authored or co-authored over 120 scientific papers on ADHD and wrote a book about how parents and professionals can empower teenagers with ADHD. I also specialize in the application of Motivational Interviewing approaches to the treatment of ADHD and am a member of the Motivational Interviewing Network of Trainers (MINT). This for includes training clinicians in strategies to adapt psychotherapeutic and pharmacological treatment for patients with ADHD, to improve treatment engagement. My research has been funded by the National Institute of Mental Health, Institute of Education Sciences, American Psychological Foundation, and Klingenstein Third Generation Foundation, I am actively involved in Children and Adults with Attention Deficit Hyperactivity Disorder (CHADD), serving on its professional advisory board, spokesperson team, and editorial advisory board for Attention Magazine. I currently serve as the Secretary of the American Professional Society of ADHD and Related Disorders, and am a member of the APSARD Adult ADHD Guidelines Task-Force. For full information about my work, please see my professional website.


Doctoral Training: State University of New York, Buffalo, Buffalo
Master's Degree: James Madison University, Harrisonburg, VA
Residency: Clinical Psychology, Florida International University, Miami

Department Affiliations

Other Affiliations

PEARL Clinic – Seattle Children’s Hospital
Training Clinic

Seattle Children’s Research Institute-Center for Child Health, Behavior, and Development

Recent Publications

Study protocol of a randomized trial of STRIPES: a schoolyear, peer-delivered high school intervention for students with ADHD.
(2023 Sep 5)
BMC Psychol 11(1): 268
Macphee FL, Brewer SK, Sibley MH, Graziano P, Raiker JS, Coxe SJ, Martin P, Van Dreel SJ, Rodriguez MO, Lyon AR, Page TF

Editorial: Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Criminality: Commentary and Caution.
(2023 Aug 30)
J Am Acad Child Adolesc Psychiatry
Stein MA, Sibley MH, Newcorn JH

A Randomized Community-Based Trial of Behavior Therapy vs. Usual Care for Adolescent ADHD: Secondary Outcomes and Effects on Comorbidity.
(2023 Sep)
Behav Ther 54(5): 839-851
Sibley MH, Graziano PA, Coxe SJ, Bickman L, Martin P, Flores S

The stability and persistence of symptoms in childhood-onset ADHD.
(2023 Jun 4)
Eur Child Adolesc Psychiatry
Van Meter AR, Sibley MH, Vandana P, Birmaher B, Fristad MA, Horwitz S, Youngstrom EA, Findling RL, Arnold LE

Effects of a Primary Care-Based Engagement Intervention for Improving Use of ADHD Treatments.
(2023 Sep-Oct)
J Pediatr Health Care 37(5): 537-547
Waxmonsky JG, Waschbusch DA, Groff D, Jairath B, Sekhar DL, Sibley MH, Logan JM, Fogel B

Show complete publication list »
Edit Profile